RDS Partnership Advises Genetec Technology Berhad on its Admission to the Main Market
RDS Partnership’s Capital Markets & M&A team is pleased to act as the solicitors for Genetec Technology Berhad (Genetec) on the successful transfer of listing of the shares of Genetec to the Main Market of Bursa Malaysia Securities Berhad (Bursa Securities) under the “Technology” sector.
Genetec is principally engaged in designing and building of smart automation systems, customised factory automated equipment and integrated systems from conceptual design, development of prototype to mass replication of equipment.
Genetec has satisfied the market capitalisation requirements of at least RM500 million based on the issue price. To date, the market capitalisation of Genetec is approximately RM1,942 million. As at 25 October 2023, the total issued share capital of Genetec is approximately RM270 million comprising of 773.8 million shares.
The firm is delighted to have played a part in the transfer listing exercise as the solicitors for Genetec. Our Capital Markets and M&A Head & Partner, Ong Eu Jin together with Lily Lee Zai-Lii (Senior Associate) and Vincent Kow Lit Han (Associate) were the key lawyers involved in this corporate exercise.
Our Capital Markets & M&A team is active in the IPO space. If you have any queries, please contact our Capital Markets and M&A Head & Partner, Ong Eu Jin at email@example.com.
More information on the listing can be found at:
27 October 2023